AlphaCentric Advisors »

Ballys Corporation shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Ballys Corporation (BALY) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Ballys Corporation

Tip: Access up to 7 years of quarterly data

All positions including Ballys Corporation held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ballys Corporation by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $332k 24k 13.71

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Vertex Pharmaceuticals Incorporated (VRTX)
Invitation Homes (INVH)
Astrazeneca Ord (AZN)
Roivant Sciences SHS (ROIV)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Axsome Therapeutics (AXSM)
Apogee Therapeutics (APGE)
Euronet Worldwide (EEFT)
Aeva Technologies Com New (AEVA)
Ishares Tr Rus 1000 Val Etf (IWD)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for AlphaCentric Advisors

Top funds holding Ballys Corporation

Standard General
Whitefort Capital Management
BlackRock
Vanguard Capital Management
Sessa Capital IM
Rathbones Brothers
Geode Capital Management
State Street Corporation
Nomura Holdings
Jb Capital Partners
Northern Trust
Regatta Capital Group
Charles Schwab Investment Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Ballys Corporation